279P Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01)

C. Saura Manich, Shanu Modi, Ian E. Krop, Y.H. Park, S-B. Kim, Kenji Tamura, Fabrice André, Hiroji Iwata, Y. Ito, Junji Tsurutani, Joohyuk Sohn, C. Lee, Y. Liu, Jillian Cathcart, Jasmeet Singh, Toshinari Yamashita